Death panel

It’s a brave new rationing world: Medicare is reportedly poised to refuse to cover Provenge, a new anti-cancer drug, arguing that although the FDA is has found it to be safe and effective, it may not be “reasonable and necessary”.

(Via Althouse.)

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s